According to Iterum Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.52. In 2022 the company made an earnings per share (EPS) of -$3.36 an increase over its 2021 EPS that were of -$11.54.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.52 | 34.52% |
2022 | -$3.36 | -70.88% |
2021 | -$11.54 | -72.13% |
2020 | -$41.40 | -61.18% |
2019 | -$106.65 | 16.48% |
2018 | -$91.56 | 57.64% |
2017 | -$58.08 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -51.77% | ๐บ๐ธ USA |